[Whitepaper by Human Metabolome Technologies Inc.]: Metabolomics Opens New Doors: Cancer, Biomarker Discovery, and Microbiome

gwenda Event News Leave a Comment

Metabolomics Opens New Doors: Cancer, Biomarker Discovery, and Microbiome Human Metabolome Technologies Inc. (herein after HMT) was born in 2003 as a start-up spun out of a Japanese University, Institute for Advanced Bio Science, Keio University. HMT is a listed, leading metabolomics company providing comprehensive and targeted metabolome analysis of blood, urine, cells, tissues, foods, and drinks by using capillary electrophoresis …

Biotech Highlight: Pacific Gene Tech (PGT)

Emily Event News Leave a Comment

Pacific Gene Tech (PGT) is an Asian vaccine company developing and commercialising first and/or best-in-class vaccines for areas of high unmet or under-served needs in food safety and livestock animal health. While working on livestock diseases, they discovered that one of their proprietary platforms has broad cross-protection for both human and livestock industries. Led by an experienced management team and advised …

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …

Who made the greatest vaccines breakthrough in Asia?

Emily Event News Leave a Comment

Prevention is better than cure, that is the basis of all public health care policy across the world. As the most populated continent in the world, Asia is the home to more than 4.2 billion people, where more than 1.6 billion of them living in tropical climate. Naturally, diseases which grow in this comfortable, warm and humid climate are highly …